What is the treatment for alcoholic withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Alcohol Withdrawal

The standard treatment for alcohol withdrawal syndrome is benzodiazepines, particularly diazepam at a dose of 10 mg 3-4 times during the first 24 hours, reducing to 5 mg 3-4 times daily as needed, combined with supportive care and nutritional supplementation. 1, 2

Assessment and Severity Classification

Severity of alcohol withdrawal should be evaluated using validated tools:

  • CIWA-Ar score:
    • ≤7: Mild (monitor, may not require medication)
    • 8-14: Moderate (initiate benzodiazepine treatment)
    • ≥15: Severe (aggressive benzodiazepine treatment, consider inpatient management) 1

Pharmacological Management

First-Line Treatment: Benzodiazepines

  • Diazepam is preferred due to:

    • Shortest time to peak effect (facilitates rapid symptom control)
    • Longest elimination half-life (provides smoother withdrawal with self-tapering effect)
    • Decreased risk of breakthrough symptoms and seizures 3
  • Dosing protocol:

    • Initial: 10 mg 3-4 times during first 24 hours
    • Maintenance: Reduce to 5 mg 3-4 times daily as needed 2
    • Loading dose technique: Give diazepam every 1-2 hours initially until clinical improvement or mild sedation 4
  • Alternative benzodiazepines when diazepam is contraindicated:

    • Lorazepam: Preferred in elderly patients or those with severe liver disease
    • Chlordiazepoxide: Another commonly used option 1, 3

Second-Line/Adjunctive Medications

  • Carbamazepine or gabapentin: Effective for mild withdrawal symptoms or as adjuncts to benzodiazepines 5

  • Baclofen: GABA-B receptor agonist that reduces alcohol cravings; particularly useful in patients with liver disease 1

  • Avoid:

    • Phenothiazines, barbiturates, paraldehyde (due to toxicity)
    • Beta-blockers (increase risk of hallucinations)
    • Clonidine (increases risk of nightmares) 6, 4

Nutritional Support

  • Thiamine supplementation: 100-300 mg/day for 4-12 weeks to prevent Wernicke's encephalopathy 1

    • Administer 100 mg thiamine before giving dextrose-containing solutions 7
  • Nutritional requirements:

    • Protein: 1.2-1.5 g/kg/day
    • Calories: 35-40 kcal/kg/day 1
  • Additional supplements: Vitamin B12, folic acid, pyridoxine, vitamin D, and zinc 1

Management of Complications

Seizures

  • Treat with benzodiazepines (oral route preferred)
  • Phenytoin should only be used in patients with pre-existing seizure disorders 4

Hallucinations

  • Benzodiazepines are first-line
  • Haloperidol may be added for persistent hallucinations while continuing benzodiazepines 4

Delirium Tremens

  • Aggressive benzodiazepine therapy
  • Continuous monitoring of vital signs
  • Fluid-electrolyte support
  • Respiratory support if necessary 6

Treatment Setting

  • Outpatient management is appropriate for:

    • Mild to moderate withdrawal symptoms
    • No history of severe withdrawal (seizures or delirium tremens)
    • No significant comorbidities
    • Reliable support system 5
  • Inpatient management is indicated for:

    • Severe withdrawal symptoms (CIWA-Ar ≥15)
    • History of seizures or delirium tremens
    • Significant medical or psychiatric comorbidities
    • Lack of reliable support system 1, 5

Long-Term Management for Alcohol Use Disorder

After acute withdrawal management, consider:

  • Pharmacotherapy options:

    • Naltrexone: 50 mg once daily for 3-12 months (avoid in patients with liver disease) 8, 1
    • Acamprosate: 666 mg three times daily for 3-6 months (initiated 3-7 days after last alcohol consumption) 8, 1
    • Baclofen: Particularly useful in patients with liver disease 1
  • Psychosocial interventions:

    • Cognitive-Behavioral Therapy
    • Motivational Interviewing
    • Support groups (e.g., Alcoholics Anonymous)
    • Individual psychotherapy 8, 1

Monitoring and Follow-up

  • Monitor outpatients daily for up to five days after their last drink
  • Assess for symptom improvement and need for additional treatment
  • Gradually taper benzodiazepines to prevent withdrawal reactions 2, 5

Common Pitfalls to Avoid

  • Underdosing benzodiazepines: Can lead to progression of withdrawal symptoms
  • Administering thiamine after dextrose: Can precipitate Wernicke's encephalopathy
  • Relying solely on pharmacotherapy: Psychosocial interventions are essential components
  • Failing to address long-term treatment: Acute withdrawal management is only the first step toward rehabilitation 1, 7, 4

References

Guideline

Treatment of Alcohol Use Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical assessment and pharmacotherapy of the alcohol withdrawal syndrome.

Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism, 1986

Research

Alcohol Withdrawal Syndrome: Outpatient Management.

American family physician, 2021

Research

Management of alcohol withdrawal.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the recommended treatment for alcohol withdrawal anxiety?
What is the best approach to managing alcohol withdrawal?
At what time frame after the last drink can we expect alcohol withdrawal symptoms to occur?
What are the symptoms and treatment options for Alcohol Withdrawal Syndrome (AWS)?
What is the recommended management for alcohol withdrawal?
When is therapeutic drug monitoring (TDM) appropriate for a patient switched to isavuconazole (Isavuconazonium sulfate) due to acute kidney injury on liposomal amphotericin B (Amphotericin B) for invasive mucormycosis treatment?
What is the best course of action for a patient with a subtherapeutic posaconazole trough concentration of 0.4 mg/L while on posaconazole (Antifungal medication) therapy for invasive fungal infection (IFI) prophylaxis after an allogenic hematopoietic cell transplant?
What are the diagnostic criteria and treatment options for common neurology diseases?
What is the preferred antiseptic solution for preoperative antisepsis, 0.7% iodine (iodine) povacrylex in 74% isopropyl alcohol or 2% chlorhexidine (chlorhexidine) gluconate in 70% isopropyl alcohol, for surgical site infection prevention?
What is the risk for surgical site infection (SSI) in a patient with complex medical history undergoing coronary artery bypass graft surgery with chlorhexidine gluconate in alcohol for preoperative skin antisepsis?
What are potential systemic treatments for a 63-year-old woman with severe widespread cutaneous sarcoidosis who is allergic to hydroxychloroquine (Plaquenil) and doxycycline (Vibramycin)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.